Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Urogenital Neoplasms 1

Interventions

pembrolizumab 3fludarabine 3aldesleukin 3Cyclophosphamide 3cabozantinib 2Specimen Handling 2Nivolumab 2Magnetic Resonance Spectroscopy 2Ipilimumab 2Fecal Microbiota Transplantation 2CTLA-4 Antigen 2vedolizumab 1prednylidene 1olaparib 1gallium 68 PSMA-11 1enfortumab vedotin 1deltacortene 1darolutamide 1Therapeutics 1Standard of Care 1Radiosurgery 1Radiation Dose Hypofractionation 1Prednisone 1Practice Guidelines as Topic 1Pluvicto 1Mitomycin 1Lutetium-177 1Lutetium 1Loperamide 1LDP-02 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urogenital Neoplasms × Continuous Positive Airway Pressure × 90 days × Clear all
NCT07111039 2026-05-18

Compare Airway Pressure Release Ventilation (APRV) to Conventional Mechanical Ventila

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Withdrawn

Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡